Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Proportions of clinical signs at inclusion

From: Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim versus artemether - lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal

Clinical signs DPT N = 206, n (%) AL N = 197, n (%)
Fever 195 (94.7) 182 (92.4)
Headache 164 (79.6) 153 (77.7)
Asthenia 105 (51.0) 103 (52.3)
Anorexia 89 (43.4) 76 (38.6)
Rigors 56 (27.2) 44 (22.4)
Arthralgia 72 (35.0) 69 (35.0)
Abdominal pain 40 (19.4) 56 (28.4)
Pallor 39 (18.9) 39 (19.8)
Splenomegaly 24 (11.7) 12 (6.1)
Vomiting 12 (5.8) 17 (8.6)
Diffuse pain 12 (5.8) 13 (6.6)
Dizziness 6 (2.9) 8 (4.1)
Hepatomegaly 6 (2.9) 3 (1.5)
Nausea 4 (1.94) 2 (1.0)
Jaundice 3 (1.5) 5 (2.5)
Cough 2 (1) 1 (0.5)
Epigastric pain 2 (1) 1 (0.5)
Pruritus 1 (0.5) 0 (0)